Early elevations of RAS protein level and activity are critical for the development of PDAC in the context of inflammation is a research paper published in Cancer Letters (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: 1R01CA240818-01A1
Targeting NADPH Oxidase for Pancreatic Cancer Prevention and Therapy
NIH
Grant: 1R01DK123079-01
Unraveling the Role of NADPH Oxidase in Inflammation-associated Pancreatic Diseases
DOD
Grant: W81XWH-20-1-0625
DOD
Grant: E21363017
DOD
Grant: RP230446
DOD
Grant: RP210153
NCI NIH HHS
Grant: R01 CA240818
NIDDK NIH HHS
Grant: R01 DK123079
DOD
NIH
FWCI
1.40
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination
Additional file 1 of KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination